GCC Implantable Deep Brain Stimulation Devices Market Growing from US$ 16.2 Million to US$ 21.8 Million by 2033
The GCC deep brain stimulation (DBS) devices industry is witnessing steady development as healthcare providers increasingly adopt advanced neuromodulation technologies for the treatment of movement disorders, including Parkinson’s disease, essential tremor, dystonia, and other neurological conditions. Deep brain stimulation devices deliver targeted electrical impulses to specific brain...
0 Comments 0 Shares 69 Views 0 Reviews